A potential role for imaging technology in anticancer efficacy evaluations

European Journal of Cancer

Volumn 40, Issue 6, 2004, Pages 890-898

  Hollingshead, M G ^a   Bonomi, C A ^b   Borgel, S D ^b   Carter, J P ^b   Shoemaker, R ^a   Melillo, G ^b   Sausville, E A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

Bioluminescence; Cancer efficacy studies; In vivo imaging; Luciferase

Indexed keywords

ADENOSINE TRIPHOSPHATE; LUCIFERASE; LUCIFERIN; OXYGEN;

ACCURACY; ALGORITHM; ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; BIOLUMINESCENCE; CAMERA; CANCER RESEARCH; CATALYSIS; CONTROLLED STUDY; DRUG EFFICACY; EX VIVO STUDY; EXPERIMENTAL MODEL; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMAGING SYSTEM; IN VIVO STUDY; LIGHT; MEASUREMENT; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PHOTON; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; QUANTITATIVE ANALYSIS; RODENT; SAMPLE; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR CELL LINE; TUMOR GROWTH; VISCERA;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DRUG EVALUATION; HUMANS; LUCIFERASES; LUMINESCENT MEASUREMENTS; MICE; MICE, TRANSGENIC; MODELS, ANIMAL; NEOPLASMS; PHOTOGRAPHY;

EID: 1942422703     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2003.12.018     Document Type: Article

References (44)

1. Plowman J., Dykes D.J., Hollingshead M., Simpson-Herren L., Alley M.C. Human tumor xenograft models in NCI drug development. Teicher B. Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials and Approval. 1997;101-125 Humana Press, Totowa, NJ.
2. Corey E., Quinn J.E., Vessella R.L. A novel method of generating prostate cancer metastases from orthotopic implants. Prostate. 56:2003;110-114.
3. te Velde E.A., Vogten J.M., Gebbink M.F., van Gorp J.M., Voest E.E., Borel Rinkes I.H. Enhanced antitumor efficacy by combining conventional chemotherapy with angiostatin or endostatin in a liver metastasis model. Br. J. Surg. 89:2002;1302-1309.
4. Contag C.H., Jenkins D., Contag P.R., Negrin R.S. Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia. 2:2000;41-52.
5. Weissleder R., Ntziachristos V. Shedding light onto live molecular targets. Tech. Trends. 9:2003;123-128.
6. Contag P.R. Whole-animal cellular and molecular imaging to accelerate drug development. DDT. 7:2002;555-562.
7. Evelhoch J.L., Gillies R.J., Karczmar G.S.et al. Application of magnetic resonance in model systems. cancer therapeutics Neoplasia. 2:2000;152-165.
8. Mahmood U., Weissleder R. Near-infrared optical imaging of proteases in cancer. Mol. Cancer Ther. 2:2003;489-496.
9. Mankoff D.A., Dehdashti F., Shields A.F. Characterizing tumors using metabolic imaging. PET imaging of cellular proliferation and steroid receptors Neoplasia. 2:2000;71-86.
10. Ntziachristos V., Bremer C., Weissleder R. Fluorescence imaging with near-infrared light. new technological advances that enable in vivo molecular imaging Eur. Radiol. 13:2003;195-208.
11. Paulus M.J., Gleason S.S., Kennel S.J., Hunsicker P.R., Johnson D.K. High resolution X-rad computed tomography. an emergin tool for small animal cancer research Neoplasia. 2:2000;62-70.
12. Rice B.W., Cable M.D., Nelson M.B. In vivo imaging of light-emitting probes. J. Biomed. Optics. 6:2001;432-440.
13. Rudin M., Weissleder R. Molecular imaging in drug discovery and development. Nat Reviews Drug Discovery. 2:2003;123-131.
14. Bremer C., Ntziachristos V., Weissleder R. Optical-based molecular imaging. contrast agents and potential medical applications Eur. Radiol. 13:2003;231-243.
15. Bremer C., Mustafa M., Bogdanov A. Jr., Ntziachristos V., Petrovsky A., Weissleder R. Stead-state blood volume measurements in experimental tumors with different angiogenic burdens a study in mice. Radiology. 226:2003;214-220.
16. Kim R.Y., Savellano M.D., Weissleder R., Bogdanov A. Jr. Steady-state and dynamic contrast MR imaging of human prostate cancer xenograft tumors. a comparative study Technol. Cancer Res. Treat. 1:2002;489-495.
17. Kruger R.A., Kiser W.L., Reinecke D.R., Kruger G.A., Miller K.D. Thermoacoustic molecular imaging of small animals. Mol. Imaging. 2:2003;113-123.
18. Tai Y.C., Chatziioannou A.F., Yang Y.et al. MicroPET II. design, development and initial performance of an improved microPET scanner for small-animal imaging Phys. Med. Biol. 48:2003;1519-1537.
19. Cherry S.R., Gambhir S.S. Use of positron emission tomography in animal research. ILAR J. 42:2001;219-232.
20. Cherry S.R. Fundamentals of positron emission tomography and application in preclinical drug development. J. Clin. Pharmacol. 41:2001;482-491.
21. Yang, H., Berger, F., Tran, C., Gambhir, S.S., Sawyers, C.L., MicroPET imaging of prostate cancer in LNCAP-SR39TK-GFP mouse xenografts. Prostate 2003, 55, 39-47.
22. Hooper C.E., Ansorge R.E., Browne H.M., Tomkins P. CCD imaging of luciferase gene expression in single mammalian cells. J. Biolumin. Chemilumin. 5:1990;123-130.
23. Bhaumik S., Gambhir S.S. Optical imaging of Renilla luciferase reporter gene expression inliving mice. Proc. Natl. Acad. Sci. U.S.A. 99:2002;377-382.
24. Bronstein I., Fortin J., Stanley P.E., Stewart S.A.B., Kricka L.J. Chemiluminescent and bioluminescent reporter gene assays. Analyt. Biochem. 219:1994;169-181.
25. Diehn F.E., Costouros N.G., Miller M.S.et al. Noninvasive fluorescent imaging reliably estimates biomass in vivo. BioTechniques. 33:2002;1250-1255.
26. Burgos J.S., Rosol M., Moats R.A., Khankaldyyan V., Kohn D.B., Nelson M.D. Jr., Laug W.E. Time course of bioluminescent signal in orthotopic and heterotopic brain tumors in nude mice. BioTechniques. 34:2003;1184-1188.
27. Mahmood U., Tung C.-H., Tang Y., Weissleder R. Feasibility of in vivo multichannel optical imaging of gene expression. experimental study in mice Radiology. 224:2002;446-451.
28. Moon W.K., Lin Y., O'Loughlin R., Tang Y., Kim D.-E., Weissleder R., Tung C.-H. Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate. Bioconjugate Chem. 14:2003;539-545.
29. Petrovsky A., Schellenberger E., Josephson L., Weissleder R., Bodganov A. Jr. Near-infrared fluorescent imaging of tumor apoptosis. Cancer Res. 63:2003;1936-1942.
30. Schellenberge E.A., Bogdanov A. Jr., Petrovsky A., Ntziachristos V., Weissleder R., Josephson L. Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy. Neoplasia. 5:2003;187-192.
31. Graves E.E., Ripoll J., Weissleder R., Ntziachristos V. A submillimeter resolution fluorescence molecular imging system for small animal imaging. Med. Phys. 30:2003;901-911.
32. Wang J.W., Yang M., Wang X., Sun F.X., Li S.M., Yagi S., Hoffman R.M. Antimetastatic efficacy of oral 5-FU imaged by green fluorescent protein in real time. Anticancer Res. 23:2003;1-6.
33. Yamamoto N., Yang M., Jiang P.et al. Clin. Exp. Metastasis. 20:2003;181-185.
34. deWet J.R., Wood K.V., Jekinski D.R., DeLuca M. Cloning of firefly luciferase cDNA and the expression of active luciferase in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 82:1985;7870-7873.
35. de Wet J.R., Wood K.V., DeLuca M., Helinski D.R., Subramani S. Firefly luciferase gene. structure and expression in mammalian cells Mol. Cell. Biol. 7:1987;725-737.
36. Contag C.H., Spilman S.D., Contag P.R.et al. Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem. Photobiol. 66:1997;523-531.
37. Edinger M., Sweeney T.J., Tucker A.A., Olomu A.B., Negrin R.S., Contag C.H. Noninvasive assessment of tumor cell proliferation in animal models. Neoplasia. 1:1999;303-310.
38. Himmler A., Stratowa C., Czernilofsky A.P. Functional testing of human dopamine D1 and D5 receptors expressed in stable camp-responsive luciferase reporter cell lines. J. Recept. Res. 13:1993;79-94.
39. Nguyen, J.T., Machado, H., Herschman, H.R., Repetitive, noninvasive imaging of cyclooxygenase-w gene expression in living mice. Molec. Imaging Biol., 2003, 5, 248-256.
40. Pazzagli M., Devine J.H., Peterson D.O., Baldwin T.O. Use of bacterial and firefly luciferases as reporter genes in DEAE-dextran-mediated transfection of mammalian cells. Anal. Biochem. 204:1992;315-323.
41. Pons M., Gagne D., Nicolas J.C., Mehtali M. A new cellular model of response to estrogens. a bioluminescent test to characterize (anti) estrogen molecules Biotechniques. 9:1990;450-459.
42. Thompson J.F., Hayes L.S., Lloyd D.B. Modluation of firefly luciferase stability and impact on studies of gene regulation. Gene. 103:1991;171-177.
43. Rapisarda A., Uranchimeg B., Scudiero D.A.et al. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. Cancer Res. 62:2002;4316-4324.
44. Hollingshead M., Plowman J., Alley M., Mayo J., Sausville The hollow fiber assay. Fiebig H.H., Burger A.M. Contributions to Oncology Vol 54. Relevance of Tumor Models for Anticancer Drug Development:1999;109-120 Karger, Basel.